RBC Bioscience Balance Sheet Health
Financial Health criteria checks 2/6
RBC Bioscience has a total shareholder equity of NT$248.1M and total debt of NT$460.4M, which brings its debt-to-equity ratio to 185.5%. Its total assets and total liabilities are NT$771.7M and NT$523.6M respectively. RBC Bioscience's EBIT is NT$29.2M making its interest coverage ratio 3. It has cash and short-term investments of NT$76.7M.
Key information
185.5%
Debt to equity ratio
NT$460.41m
Debt
| Interest coverage ratio | 3x |
| Cash | NT$76.73m |
| Equity | NT$248.14m |
| Total liabilities | NT$523.57m |
| Total assets | NT$771.71m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6848's short term assets (NT$164.2M) exceed its short term liabilities (NT$123.4M).
Long Term Liabilities: 6848's short term assets (NT$164.2M) do not cover its long term liabilities (NT$400.1M).
Debt to Equity History and Analysis
Debt Level: 6848's net debt to equity ratio (154.6%) is considered high.
Reducing Debt: 6848's debt to equity ratio has increased from 66.7% to 185.5% over the past 5 years.
Debt Coverage: 6848's debt is not well covered by operating cash flow (9.7%).
Interest Coverage: 6848's interest payments on its debt are well covered by EBIT (3x coverage).